SCHEMBL21929624

SCHEMBL21929624

CC1(C)c2ccccc2N(c2ccccc2-c2ccc(-c3cccnc3C#N)cc2)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HSD17B10 Q99714 1/20 0.41
AR P10275 1/20 0.37
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
PGR P06401 1/20 0.33
MGLL Q99685 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
GRM1 Q13255 2/20 0.32
BACE1 P56817 1/20 0.32
METAP2 P50579 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
FABP1 P07148 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
GRM5 P41594 1/20 0.32
TNF P01375 1/20 0.32
MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21922017 0.92 ALDH1A1 (0.39) HTTALDH1A1HSD17B10ARPRMT5
SCHEMBL21927295 0.91 HTT (0.35) HTTALDH1A1HSD17B10ARPGR
SCHEMBL21922081 0.90 KMT2A (0.35) HTTALDH1A1HSD17B10ARPGR
SCHEMBL21927291 0.85 AR (0.39) HTTALDH1A1HSD17B10ARPRMT5
SCHEMBL21929627 0.84 ALDH1A1 (0.44) HTTALDH1A1HSD17B10ARPGR
SCHEMBL21927705 0.83 AR (0.41) HTTALDH1A1HSD17B10ARPRMT5
SCHEMBL21928466 0.82 ALDH1A1 (0.40) HTTALDH1A1HSD17B10PRMT5WDR77
SCHEMBL21927338 0.82 AR (0.40) HTTALDH1A1HSD17B10ARPRMT5
SCHEMBL21929619 0.81 ALDH1A1 (0.44) HTTALDH1A1HSD17B10PRMT5WDR77
SCHEMBL21928516 0.80 ALDH1A1 (0.40) HTTALDH1A1HSD17B10PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CCNT1, CCNA1, CCNE2 HTT 2197/4885ALDH1A1 511/4885HSD17B10 3516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.